⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27725584 | 0.95 | — | — | |
| SCHEMBL27787581 | 0.84 | — | — | |
| SCHEMBL39601 | 0.80 | — | — | |
| SCHEMBL9930262 | 0.80 | — | — | |
| SCHEMBL9383004 | 0.80 | — | — | |
| SCHEMBL27802098 | 0.80 | — | — | |
| SCHEMBL270171 | 0.79 | — | — | |
| SCHEMBL15676 | 0.78 | — | — | |
| SCHEMBL212534 | 0.78 | — | — | |
| SCHEMBL210425 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348421-A1 | 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) | 2023-11-02 | — | — | US | claimed |
| CN-116730981-A | 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof | 山东绿叶制药有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-114728933-B | 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof | 山东绿叶制药有限公司 | 2023-06-16 | — | — | CN | claimed |
| EP-4186893-A1 | 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) | 2023-05-31 | — | — | EP | claimed |
| US-7074387-B2 | DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production | SCHERING AG (DE) | 2006-07-11 | — | — | US | claimed |
| CN-1230362-C | Method and system for producing packaging materials, containers and other products | CASSIUKIE INDUSTRY INC E (US) | 2005-12-07 | — | — | CN | claimed |
| CN-1173861-C | Organically bonded, inorganically filled articles from sheet material and methods and systems for making same | E�����ݻ���ҵ����˾ | 2004-11-03 | — | — | CN | claimed |
| CN-1403349-A | Method and system for producing packaging materials, containers and other products | KHASHOGGI E IND (US) | 2003-03-19 | — | — | CN | claimed |
| CN-1250736-A | Organically bonded, inorganically filled articles from sheet material and methods and systems for making same | KHASHOGGI E IND (US) | 2000-04-19 | — | — | CN | claimed |
| US-5674467-A | USED IN NMR DIAGNOSIS, RADIODIAGNOSIS OR RADIOTHERAPY | INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) | 1997-10-07 | — | — | US | claimed |
| CN-1099711-A | Method and system for producing packaging materials, containers and other articles | KHASHOGGI E IND (US) | 1995-03-08 | — | — | CN | claimed |
| CN-116730981-B | 5-HT2AReceptor inhibitor or inverse agonist, preparation method and application thereof | 山东绿叶制药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-20230348421-A1 | 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-116730981-A | 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof | 山东绿叶制药有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-114728933-B | 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof | 山东绿叶制药有限公司 | 2023-06-16 | — | — | CN | disclosed |
| US-4289883-A | ADRENERGIC BLOCKING AGENTS OF EXCELLENT CARDIOSELECTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-09-15 | — | — | US | disclosed |
| US-4239747-A | Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) useful as x-ray contrast agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-12-16 | — | — | US | disclosed |
| US-4210753-A | TREATMENT OF CARDIAC DISORDERS AND CHRONIC LUNG DISEASE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1980-07-01 | — | — | US | disclosed |
| US-4140805-A | SOLVENT EXTRACTION OF ALFALFA AND CLOVER | EDWARDS GEORGE W | 1979-02-20 | — | — | US | disclosed |
| US-4108995-A | CEREBRAL BLOOD FLOW | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-08-22 | — | — | US | disclosed |